Global Nicotine Gum Market Overview
Nicotine Gum Market Size was valued at USD 1.5 billion in 2022. The Nicotine Gum industry is projected to grow from USD 1.569 Billion in 2023 to USD 2.055 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6% during the forecast period (2023 - 2030). Concerns about smoking, increased health awareness, and government efforts to subsidize NRT product costs are the main factors propelling the growth of the worldwide nicotine gum, thus driving the growth of the market of nicotine gum. These are just a few of the market drivers that are driving the market.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Nicotine Gum Market Trends
- Growing concerns due to smoking, rising health awareness, and government initiatives to propel market growth
Government efforts to reduce smoking rates have increased significantly. Governments in every region support broad strategies to reduce tobacco use, including several measures like cigarette promotion and advertising bans. Combining steps to stop smuggling and sustainably raising tobacco taxes may limit smoking in the workplace and other public areas. Further, strong health warnings on tobacco-based products, tobacco regulation to standards, smoking cessation support, and promotion of anti-smoking campaigns are examples of such measures that have increased consumers' search for alternatives to reduce their tobacco consumption, driving demand for market growth. Rising urbanization, product developments, including the creation of nicotine products (gums), and intensive research and development efforts are some of the reasons driving this industry. In developing and developed countries, various government and non-governmental organizations (NGOs) encourage smoking cessation aids like nicotine gums and other nicotine replacement products to help people, especially young people, who are addicted to tobacco. Numerous influential parties support anti-smoking initiatives and frequently introduce products to help people stop smoking, like gum and lozenges. Using these items with successful cessation programs increases the likelihood that residents will stop smoking. Thus, this factor is driving the market CAGR.
The main element driving the market growth rate is the rise in the number of people seeking to quit smoking due to increased knowledge of the health risks associated with smoking. Also, the market has seen a marked rise in demand for nicotine cessation from rehab centers and medical establishments in both developed and developing nations worldwide. Moreover, the market is primarily driven by the rising incidence of lung cancer, heart conditions, and respiratory problems. It is brought on by rising tobacco use in distinctive ways that seriously jeopardize public safety. These elements might spur the market for nicotine gum to expand. Thus, it is anticipated that this aspect will accelerate nicotine gum market revenue globally.
Segment Insights
Nicotine Gum Product Type Insights
The Nicotine Gum market segmentation, based on product type includes, 2mg, 4mg. The 2mg segment held the majority share in 2022 in the nicotine gum industry data. Since it benefits light smokers who consume fewer than 25 cigarettes daily, the 2MG sector commands the largest market share. Also, the simple accessibility of 2 MG nicotine gums in various tastes draws in potential customers, projected to fuel demand throughout the forecast period. Tobacco dependence-related cravings and withdrawal symptoms are lessened and controlled by Nicorette 2 MG gum. It is recommended as a safer alternative to smoking for smokers and others around them. It is also indicated to help smokers who wish to quit or decrease before quitting.
Nicotine Gum Category Insights
The Nicotine Gum market segmentation, based on category, includes flavored, and plain. The flavored segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2022-2030. Due to the variety of flavor possibilities, which range from mint and cinnamon to different fruit flavors, and doses that range from 2 to 6 mg, though it is most frequently supplied in 2 and 4 mg levels, the flavored category accounted for a greater market share., hence contributing in the growth of the nicotine gum.
Figure 1: Nicotine Gum Market, by Category, 2022 & 2030 (USD Billion)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Nicotine Gum Distribution Channel Insights
The Nicotine Gum market segmentation, based on distribution channel includes, store based, non-stored based. The store-based segment held the majority share in 2022 in the nicotine gum industry data. Since it provides a high level of assurance for product standards and customer confidence, store-based hold the largest market share. Most nations only allow pharmacies to sell nicotine gum and other nicotine replacement medications. With general practitioners and skilled pharmacists in the stores, sales and marketing of these products are anticipated to rise in the years to come.
Nicotine Gum Regional Insights
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Nicotine Gum market accounted for USD 0.687 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. A rise in the proportion of consumers in North America who are concerned about their health has been fueled by government programmes and advertising campaigns. Significant brands are also present in the area, concentrating on product improvements to meet the market's growing demand and gain a competitive edge. For instance, Nicorette introduced a smoother-textured nicotine gum product in May 2019 that was covered with frozen mint lozenges. Consequently, it is anticipated that these factors will increase the market share of nicotine gum over the study period. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.
Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 3: NICOTINE GUM MARKET SHARE BY REGION 2022 (%)Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe Nicotine Gum market accounts for the second-largest market share. Due to rising nicotine product sales in nations like the U.K., Germany, Italy, and France, the European Market also retains a sizeable portion. Also, the regional government is placing great emphasis on implementing cessation plans. Moreover, UK market of nicotine gum held the largest market share, and the Germany Nicotine Gum was the fastest growing market in the region.
Asia Pacific Nicotine Gum Market is expected to grow at the fastest CAGR from 2022 to 2030. Over the projected period, the Asia Pacific region is expected to have the quickest growth rate. This results from the extremely dynamic industry, rising demand for such novel goods, increased competition among the major tobacco corporations, and expanding market potential, particularly in Japan. Furthermore, tight laws against smoking passed in China and India are projected to raise demand for alternative items like gums. Further, the China Nicotine Gum held the largest market share, and the India market of nicotine gum was the fastest-growing market in the region.
Nicotine Gum Key Market Players & Competitive Insights
Major market players are spending a lot of money on R&D to increase their product lines, which will help the Nicotine Gum market grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the nicotine gum industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.
One of the primary business strategies adopted by manufacturers in the nicotine gum industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, nicotine gum industry has provided medicine with some of the most significant benefits. The Nicotine Gum market major player such as Novartis Consumer Health Inc, Pharmacia, Revolymer, Alchem International, Fertin Pharma, GlaxoSmithKline.
Several nicotine replacement therapy medications with nicotine polacrilex go by the brand name Nicorette. Nicorette was the first nicotine replacement product on the market and was created by AB Leo in Sweden in the late 1970s. In May 2019, Nicorette introduced a smoother-textured nicotine gum product coated in frozen mint lozenges. Compared to other nicotine lozenges, which can occasionally have a gritty feel, the coating helps to deliver a punch of mint flavor with a smoother texture.
Philip Morris International Inc., an American tobacco corporation, sells its goods in over 180 nations. Marlboro is the brand's best-known and most popular product. One of the firms that make up Big Tobacco is frequently referred to as Philip Morris International. Philip Morris International purchased Fertin Pharma in July 2021. Fertin Pharma's business creates and manufactures pharmaceutical and health products using intra- and extra-oral delivery methods.
Key Companies in the Nicotine Gum market includes
- Novartis Consumer Health Inc
- Pharmacia
- Revolymer
- Alchem International
- Fertin Pharma
- GlaxoSmithKline
- Perrigo Company
- Fertin Pharma
- Pfizer Inc.
- Cambrex Corporation
- Johnson & Johnson
- Reynolds American
Nicotine Gum Industry Developments
February 2022: The first generic nicotine chewing gum, sold under the trade name Nicotin beta, has been introduced to the German market by Enorama Pharma's business partner, betapharm Arzneimittel GmbH. Nicotin Beta will promote the benefits of NRT with a generic medication (Nicotine Replacement Therapy).
August 2021: GSK introduced Nicotinell, a line of products for treating tobacco dependence that comprises a patch, gum, and lozenge. It is intended to aid smokers in ending their nicotine dependence.
Nicotine Gum Market Segmentation
Nicotine Gum Product Type Outlook (USD Billion, 2018-2030)
Nicotine Gum Category Outlook (USD Billion, 2018-2030)
Nicotine Gum Distribution Channel Outlook (USD Billion, 2018-2030)
- Store Based
- Non-Store Based
Nicotine Gum Regional Outlook (USD Billion, 2018-2030)
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Australia
- Rest of Asia-Pacific
- Rest of the World
- Middle East
- Africa
- Latin America
Report Attribute/Metric |
Details |
Market Size 2022 |
USD 1.5 billion |
Market Size 2023 |
USD 1.56 billion |
Market Size 2030 |
USD 2.055 billion |
Compound Annual Growth Rate (CAGR) |
4.6% (2023-2030) |
Base Year |
2022 |
Market Forecast Period |
2023-2030 |
Historical Data |
2018 - 2021 |
Market Forecast Units |
Value (USD Billion) |
Report Coverage |
Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered |
Product Type, Category, Distribution Channel and Region |
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
Countries Covered |
The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled |
Novartis Consumer Health Inc, Pharmacia, Revolymer, Alchem International, Fertin Pharma, GlaxoSmithKline |
Key Market Opportunities |
Development of organized retail in emerging countries |
Key Market Dynamics |
Smoking-related worries and growing health consciousness |
Nicotine Gum Market Highlights:
Frequently Asked Questions (FAQ) :
The Nicotine Gum market size was valued at USD 1.56 Billion in 2023.
The market is projected to grow at a CAGR of 4.6% during the forecast period, 2022-2030.
North America had the largest share in the market
The key players in the market are Novartis Consumer Health Inc, Pharmacia, Revolymer, Alchem International, Fertin Pharma, GlaxoSmithKline.
The 2mg category dominated the market in 2022.
The store-based had the largest share in the market.